SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (1929)3/23/2002 7:38:18 PM
From: William Partmann  Read Replies (1) | Respond to of 10345
 
Richard, it has never been disclosed by Merck or Elan. At one time, I thought I had deduced the product by process of elimination. I'll see if I can't find my notes.

bill



To: scaram(o)uche who wrote (1929)3/23/2002 7:51:52 PM
From: William Partmann  Read Replies (1) | Respond to of 10345
 
Richard, this is a possibility. I believe the product involves Elan's nanotechnology.


Substance P antagonist
• prevention of chemotherapy-induced nausea and vomiting